Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    21562061 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed
Has Results
Effect of Rosiglitazone Versus Placebo on Cardiovascular Performance and Myocardial Triglyceride
Condition: Diabetes Mellitus, Type 2
Interventions: Drug: rosiglitazone;   Drug: placebo

Indicates status has not been verified in more than two years